Nature Communications (Aug 2021)

Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting

  • Wei Liu,
  • Lei Xie,
  • Yao-Hui He,
  • Zhi-Yong Wu,
  • Lu-Xin Liu,
  • Xue-Feng Bai,
  • Dan-Xia Deng,
  • Xiu-E Xu,
  • Lian-Di Liao,
  • Wan Lin,
  • Jing-Hua Heng,
  • Xin Xu,
  • Liu Peng,
  • Qing-Feng Huang,
  • Cheng-Yu Li,
  • Zhi-Da Zhang,
  • Wei Wang,
  • Guo-Rui Zhang,
  • Xiang Gao,
  • Shao-Hong Wang,
  • Chun-Quan Li,
  • Li-Yan Xu,
  • Wen Liu,
  • En-Min Li

DOI
https://doi.org/10.1038/s41467-021-25202-5
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 18

Abstract

Read online

Proteomics can aid in the identification of molecular subtypes in cancers. Here, the authors perform proteomic profiling of 124 paired oesophageal cancer and adjacent non-tumour tissues and identify two subtypes that are associated with patient survival for therapeutic targeting.